丘脑底核脑深部电刺激治疗原发性Meige综合征:临床结局与预测因素
该研究回顾性纳入2016年1月至2023年6月在本机构接受双侧丘脑底核脑深部电刺激(STN-DBS)的51例Meige综合征患者,平均随访27.3±18.0个月;末次随访BFMDRS运动评分平均改善58.9%、残疾评分平均改善44.6%(均p<0.001),抑郁与焦虑评分分别改善35.3%和34.2%,总体认知保持稳定。
要点
- STN-DBS可改善Meige综合征的运动症状,BFMDRS运动评分平均改善58.9%(p<0.001)。
- 抑郁与焦虑评分分别改善35.3%和34.2%,生活质量明显提升,总体认知保持稳定。
- 病程、术前焦虑严重程度及背外侧STN激活组织体积是运动结局的独立预测因素。
核心结论
- 研究结果支持STN-DBS是改善Meige综合征运动与非运动症状的有效且前景可期的治疗;及时诊断、治疗术前焦虑及将电极精准置入背外侧STN对获得最佳临床结局至关重要。
研究设计与样本
- 回顾性连续纳入2016年1月至2023年6月在本机构接受双侧STN-DBS的Meige综合征患者,最终纳入51例,平均随访27.3±18.0个月。
- 采用标准化评定量表在基线和末次术后随访评估运动表现及情绪、认知功能和生活质量等非运动特征。
- 采用单因素和多因素线性回归模型评估影响术后运动结局的临床与人口学因素。
主要发现
- BFMDRS运动评分由术前12.9±5.2改善至末次随访5.3±4.2,平均改善58.9%(p<0.001)。
- BFMDRS残疾评分由5.6±3.3改善至2.9±2.9,平均改善44.6%(p<0.001)。
- 汉密尔顿抑郁与焦虑评定量表评分分别改善35.3%和34.2%,术后36项简表健康调查评分提示生活质量明显提升;总体认知在治疗后保持稳定。
- 多因素线性回归显示,病程(β=-0.241,p=0.027)、术前焦虑严重程度(β=-0.386,p=0.001)及背外侧(感觉运动)STN内激活组织体积(β=0.483,p<0.001)是运动结局的独立预测因素。
临床怎么用
- 作者认为STN-DBS是Meige综合征运动与非运动症状的有效且前景可期的治疗。
- 作者提出及时诊断、治疗术前焦虑及将电极精准置入背外侧STN对获得最佳临床结局至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has demonstrated efficacy against multiple types of dystonia, but only a few case reports and small-sample studies have investigated the clinical utility of STN-DBS for Meige syndrome, a rare but distressing form of craniofacial dystonia. Furthermore, the effects of DBS on critical neuropsychological sequelae, such as depression and anxiety, are rarely examined. In this study, the authors investigated the therapeutic efficacy of STN-DBS for both motor and psychiatric symptoms of Meige syndrome. METHODS: The authors retrospectively reviewed consecutive patients with Meige syndrome receiving bilateral STN-DBS at their institution from January 2016 to June 2023. Motor performance and nonmotor features including mood, cognitive function, and quality of life (QOL) were evaluated using standardized rating scales at baseline and at final postoperative follow-up. Clinical and demographic factors influencing postoperative motor outcome were evaluated by uni- and multivariable linear regression models. RESULTS: Fifty-one patients were ultimately included, with a mean ± SD follow-up duration of 27.3 ± 18.0 months. The mean Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) movement score improved from 12.9 ± 5.2 before surgery to 5.3 ± 4.2 at the last follow-up (mean improvement 58.9%, p < 0.001) and the mean BFMDRS disability score improved from 5.6 ± 3.3 to 2.9 ± 2.9 (mean improvement 44.6%, p < 0.001). Hamilton Depression and Anxiety Rating Scale scores also improved by 35.3% and 34.2%, respectively, and the postoperative 36-item Short-Form Health Survey score indicated substantial QOL enhancement. Global cognition remained stable after treatment. Multiple linear regression analysis identified disease duration (β = -0.241, p = 0.027), preoperative anxiety severity (β = -0.386, p = 0.001), and volume of activated tissue within the dorsolateral (sensorimotor) STN (β = 0.483, p < 0.001) as independent predictors of motor outcome. CONCLUSIONS: These findings support STN-DBS as an effective and promising therapy for both motor and nonmotor symptoms of Meige syndrome. Timely diagnosis, treatment of preoperative anxiety, and precise electrode placement within the dorsolateral STN are essential for optimal clinical outcome.
引用
- Xie H, Shan M, Wang S, et al. Deep brain stimulation of the subthalamic nucleus for primary Meige syndrome: clinical outcomes and predictive factors. J Neurosurg. 2024. PMID: 38241667. doi:10.3171/2023.11.JNS232075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。